Evidence map›Paper›PMID 42557568›Full record

ArticleBMC biology2026

Rhobot-Screen: an integrated robotic platform for functional screening of rhodopsin variants.

Takashi Nagata, Masae Konno, Daisuke R Hashimoto, Keiichi Inoue

Abstract read
In one paragraph

Article in BMC biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Takashi Nagata *The Institute for Solid State Physics, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8581, Japan.ORCID 0000-0001-5379-2951
Masae Konno *The Institute for Solid State Physics, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8581, Japan.ORCID 0000-0002-0605-1816
Daisuke R HashimotoThe Institute for Solid State Physics, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8581, Japan.ORCID 0009-0007-7634-6664
Keiichi InoueThe Institute for Solid State Physics, The University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba, 277-8581, Japan. inoue@issp.u-tokyo.ac.jp.ORCID 0000-0002-6898-4347

Funding

Japan Science and Technology Agency JPMJCR22N2Japan Society for the Promotion of Science JP23H04863Japan Society for the Promotion of Science JP23K05007Japan Society for the Promotion of Science JP24H02268Ministry of Education, Culture, Sports, Science and Technology JPMXP1323015482
6 · The paper itself

Abstract

backgroundRhodopsins are photoreceptive membrane proteins widely used as optogenetic tools in basic research and medical applications, and extensive mutational studies have been performed to improve or modify their functional properties. Recently, in the broader field of protein engineering, data-driven strategies based on machine learning have attracted increasing attention, as they enable efficient exploration of vast mutational spaces with a reduced number of experiments. Such approaches require large, consistent datasets that link predefined mutations to quantitative functional properties, which necessitates systematic construction and characterization of targeted variants rather than random mutagenesis. For rhodopsins, however, generating these datasets remains challenging due to operator-dependent, non-integrated workflows that are difficult to scale and standardize.

resultsTo address this limitation, we developed an automated screening platform termed Rhobot-Screen, based on a robotic liquid-handling workstation, which integrates multiple experimental steps into a standardized workflow with reduced dependence on operator-specific expertise. This platform performs site-directed mutagenesis, plasmid preparation, protein expression in bacterial and mammalian cultured cells, and functional characterization in a 96-well format through automated liquid-handling operations. For spectroscopic characterization, we established a 96-well plate-based hydroxylamine bleaching assay that determines absorption maximum wavelengths without protein purification. As a demonstration of the platform, we comprehensively mutated three established color-tuning residues in Gloeobacter rhodopsin, generating 57 single-point variants. Using Rhobot-Screen, the absorption maxima of 46 variants were successfully determined. The resulting dataset revealed position-dependent relationships between spectral shifts and amino acid physicochemical properties, with clear correlations between absorption wavelength and side-chain volume at positions 129 and 256, but not at position 226. The platform was further extended to mammalian cell-based assays for functional characterization of animal rhodopsins.

conclusionsRhobot-Screen provides an integrated workflow in which all liquid-handling steps for systematic construction and spectroscopic characterization of rhodopsin variants are automated in a 96-well plate format under standardized conditions. By automating and standardizing multiple operator-dependent steps, the platform provides a reproducible framework for acquiring quantitative sequence-function data from predefined rhodopsin variants. This framework should support both mechanistic studies of rhodopsins and future data-driven engineering of rhodopsin functions.

Indexed as

RhodopsinRoboticsAnimalsMutagenesis, Site-DirectedMutationRhodopsinAutomated functional screeningColor tuningRhodopsinSite-directed mutagenesis

Identifiers

PMID42557568
PMCPMC13445694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.